Exagen (XGN) Stock: Buy, Sell, or Hold?
XGN - Exagen Inc. Common Stock
$7.88
0.47 (6.34%)
▲
5d:
-6.41%
30d:
-9.84%
90d:
+59.19%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 03, 2026
11d
Get Alerted When XGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XGN is currently trading at $7.88, which is considered slightly low relative to its 30-day fair value range of $7.76 to $8.59.
Technical Outlook: Technically, XGN is in a strong uptrend. Immediate support is located at $7.30, while resistance sits at $9.22. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.57 (+34.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XGN is in a strong uptrend. Immediate support is located at $7.30, while resistance sits at $9.22. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.57 (+34.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.76 -
$8.59
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 34.2% below Wall St target ($10.57)
- NEUTRAL: Bottoming setup forming (41/100) — watch for confirmation
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$7.76 -
$8.59
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.99
(12.5%)
Support & Resistance Levels
Support Level
$7.30
Resistance Level
$9.22
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.77
Wall Street Target
$10.57
(+34.2%)
Revenue Growth (YoY)
15.9%
Profit Margin
-26.6%
Share & Embed Analysis
Last updated: October 22, 2026 6:36 AM ET
Data refreshes hourly during market hours. Next update: 7:36 AM
Data refreshes hourly during market hours. Next update: 7:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
